U.S. Other Utilities Stock News

UnitedHealth Group (UNH) has reported new earnings, with second quarter 2026 results and an active share repurchase program giving investors updated figures to assess the health care giant’s stock. See our latest analysis for UnitedHealth Group. UnitedHealth Group’s recent earnings beat, share repurchases and raised full year outlook come against a backdrop of strong momentum, with a 90 day share price return of 18.55% and a 1 year total shareholder return of 53.71%, even though the 3 year...

Advance Auto Parts (AAP) recently filed an omnibus shelf registration covering debt, common and preferred stock, depositary shares, warrants and units, giving the company flexibility to raise capital alongside growing interest in its earnings track record. See our latest analysis for Advance Auto Parts. At a share price of $55.80, Advance Auto Parts has seen a 4.5% 1 day and 5.0% 7 day share price return, while its 30 day and 90 day share price returns have slipped, and longer term total...

In the past week, AT&T reported Q2 2026 results showing revenues of US$31,558 million and net income of US$4,627 million, with earnings per share rising to US$0.66 from US$0.62 a year earlier. Alongside an earnings beat and strong growth in Advanced Connectivity customers, AT&T lifted its 2026 share repurchase target to about US$10 billion, underscoring management’s confidence in cash generation and the fiber‑plus‑5G convergence strategy. Next, we’ll examine how AT&T’s stronger-than-expected...

Recent commentary around OSI Systems (OSIS) centers on its history of outperforming earnings estimates, with a positive Earnings ESP and favorable Zacks Rank raising expectations for another potential surprise in the upcoming quarterly report. See our latest analysis for OSI Systems. At a recent share price of US$216.70, OSI Systems has seen modest positive short term momentum, including a 7 day share price return of 1.90%. However, the 90 day share price return is down 25.94%, while the 3...

Quaker Chemical (KWR) heads into its upcoming earnings release with expectations for a year over year decline in quarterly profit, even as revenue is projected to be higher and sentiment has turned more cautious. See our latest analysis for Quaker Chemical. Quaker Chemical's share price has climbed 8.97% year to date to US$151.43, with a 7.52% 90 day share price return and a 25.80% total shareholder return over one year. However, longer term total shareholder returns over three and five years...

West Pharmaceutical Services (WST) has just posted Q2 2026 results with revenue of US$872.3 million, basic EPS of US$2.18 and net income of US$154 million, setting the tone for how investors assess its current profitability. The company has seen quarterly revenue move from US$766.5 million in Q2 2025 to US$872.3 million in Q2 2026, while basic EPS shifted over the same period from US$1.83 to US$2.18, giving investors a clear view of how the top line and per share earnings have tracked...

Centene stock has delivered a strong 1 year return while the current valuation checks still point to the shares screening as undervalued on several metrics. This raises the question of how much of that gain is already reflected in the current US$63.41 price. Over the last 1 year, Centene is up 123.4%, which puts recent buyers in profit and makes the current valuation more important for anyone considering new capital. Future growth in membership and medical cost control can support earnings,...

New Era Energy & Digital (NUAI) is under scrutiny after law firm Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential corporate wrongdoing involving the company and certain officers or directors. See our latest analysis for New Era Energy & Digital. The latest law firm investigation comes after a sharp pullback in New Era Energy & Digital's share price, which fell about 10% in the last session. This followed a 7 day share price return of around 17% and a year to date...

ATI (ATI) stock recently gained 2.17% on a weak market day, as investors focused on expectations for significant year-over-year earnings growth ahead of the company’s August 6, 2026 report. See our latest analysis for ATI. Zooming out, ATI’s recent move comes after a 90 day share price return of 28.23% and a year to date share price return of 65.94%. The 1 year total shareholder return stands at 108.23%, suggesting momentum has been building over both shorter and longer horizons. If ATI’s...

Strive’s share price has fallen sharply in recent years, yet the stock still screens as undervalued on market multiples while its broader valuation checks remain weak. This leaves investors with a mixed message on what the current price really offers. Strive has declined about 90% over the past 3 years, which signals that the market has heavily reset expectations for the business. Any improvement in Strive’s ability to turn revenue into consistent cash flow can help support the current...

FirstCash Holdings (FCFS) opened Q2 2026 with total revenue of US$1.1 billion and basic EPS of US$2.12, set against trailing 12 month EPS of US$8.81 on revenue of US$4.1 billion, alongside earnings growth of 33% over the past year. Over recent quarters the company has seen revenue move from US$830.6 million in Q2 2025 to US$1.1 billion in Q2 2026, while quarterly EPS has shifted from US$1.35 to US$2.12. This has set up a results season in which improving net margins sit at the center of the...

NetApp stock has delivered a strong 136.2% return over the past 5 years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples still point to the shares trading below their assessed value. That combination of a strong track record and indications of undervaluation puts the focus squarely on whether the current price around US$167.74 is still reasonable for new capital. Over 5 years, NetApp has returned 136.2%, which puts long term holders in a comfortable...

A recent UBS report spotlighted DLocal (NasdaqGS:DLO) as a key opportunity in global payment processing, highlighting its broad emerging markets footprint and prompting fresh attention on how the stock fits into diversified portfolios. See our latest analysis for DLocal. The recent UBS attention comes as DLocal’s share price, now at US$14.49, has logged a 30 day share price return of 18.0% and a 1 year total shareholder return of 36.1%. Longer term total shareholder returns have been more...

Dime Commercial Bancshares has almost doubled shareholders' money over the past three years, yet its current valuation checks and recent share price of US$39.56 point to a stock that screens as undervalued rather than obviously overheated. The stock has returned 95.8% over the last three years, which puts recent short term pullbacks in a wider context of strong longer term gains. For a regional lender like Dime Commercial Bancshares, investor expectations around loan growth and credit...

Lamar Advertising stock has delivered a strong 91.8% total return over the past five years, and the current valuation tension is that both the intrinsic value estimate from a Discounted Cash Flow (DCF) approach and market multiples now suggest the shares trade at a discount to their estimated worth. Over five years, Lamar Advertising has returned 91.8%, which puts more focus on whether the current price still offers an attractive entry point based on fundamentals. The company’s ability to...

Repligen has entered into a definitive agreement to acquire BioLife Solutions, the cell therapy tools company traded as NasdaqCM:BLFS. Following the deal announcement, several law firms have launched investigations into whether the transaction is fair to BioLife Solutions shareholders. The probes focus on the sale process, potential conflicts, and whether investors are receiving adequate value for their shares. BioLife Solutions sits at the intersection of cell and gene therapy workflows,...

Honeywell International (HON) has put up a striking Q2 2026 print, with revenue of about US$9.7 billion and basic EPS of US$17.92, while trailing 12 month figures show revenue of roughly US$38.1 billion and EPS of US$26.04 backed by net income of US$8.3 billion. Over the past few quarters, the company has seen revenue move between roughly US$8.9 billion and US$10.4 billion as EPS ranged from US$0.98 to US$5.75 before the latest spike. This leaves investors to weigh how much of the current...

Danaher (DHR) is back in focus after its second quarter report paired higher sales and net income with fresh third quarter revenue guidance, giving investors an updated view on the company’s near term outlook. See our latest analysis for Danaher. Danaher’s share price has been under pressure this year, with a year to date share price return down 16.88%, while the 1 year total shareholder return is down 6.12%. This suggests momentum has softened even as recent earnings and buyback activity...

First Merchants (FRME) stock came under pressure after second quarter 2026 results showed lower net income and earnings per share, along with higher credit costs, despite loan growth and a wider net interest margin. See our latest analysis for First Merchants. At a share price of $43.18, First Merchants has a 1 day share price return of 3.08%, a 90 day share price return of 9.07%, and a 3 year total shareholder return of 53.16%. This suggests longer term holders have seen stronger gains than...

Mondelez International stock has gained 12.8% year to date, yet its valuation checks send mixed signals, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to significant upside while market multiples suggest the shares already trade on the rich side. The 12.8% year to date return suggests the market has recently been more optimistic about Mondelez International, even though longer term returns have been less supportive. Investment in emerging snack brands such as Final Boss...

Zimmer Biomet Holdings has appointed Chintan Desai as president of its Asia Pacific Region, effective 14 July 2026, succeeding Sang Yi after a transition period through 28 August 2026. Desai’s long tenure across Alcon and GE Healthcare, spanning sales, supply chain, finance, and digital solutions in Asia Pacific, could materially shape how Zimmer Biomet runs this key growth region. We’ll now examine how Desai’s extensive Asia Pacific MedTech leadership experience could influence Zimmer...

Utah Medical Products (UTMD) opened Q2 2026 with total revenue of $8.5 million and basic EPS of $0.84, alongside net income excluding extra items of $2.7 million, providing a clear snapshot of how the business is currently earning its money. The company has reported quarterly revenue moving from $9.7 million and EPS of $0.92 in Q1 2025 to $8.5 million and EPS of $0.84 in Q2 2026, with trailing 12 month revenue at $36.1 million and EPS at $3.28. Investors are weighing these results against a...

City Holding (CHCO) shares are in focus after the company reported second quarter and six month 2026 results, with higher net interest income and largely unchanged net income compared with last year. See our latest analysis for City Holding. City Holding’s latest earnings and buyback update come as the stock trades at $139.62, with a 30-day share price return of 6.33% and a year-to-date share price return of 16.46%, while the 5-year total shareholder return of 112.58% indicates momentum has...

Cass Information Systems (CASS) has just posted Q2 2026 revenue of US$54.5 million and basic EPS of US$0.83, with the trailing twelve months showing US$215.0 million of revenue and basic EPS of US$2.83 as the latest snapshot of its earnings power. Over recent quarters the company has seen revenue move from US$48.6 million in Q2 2025 to US$54.0 million in Q3 2025, US$53.4 million in Q4 2025, US$53.1 million in Q1 2026 and now US$54.5 million. Quarterly basic EPS shifted from US$0.39 in Q2 2025...